- Home
- / Inhibikase Therapeutics
- / Operating Metrics
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
InhibikaseTherapeutics key operating metrics including Preclinical Phase Products.
Preclinical Phase Products
4
Q3, 2020
Phase I Trials Products
1
Q3, 2020